Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonarda Galiuto

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
European Heart Journal|January 6, 2021
Physical activity and mortality reduction: is volume or intensity the key variable?Leonarda Galiuto, Carlo Patrono
European Heart Journal|November 10, 2023
More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostatMassimo Volpe, Leonarda Galiuto
European Heart Journal|October 14, 2020
Weak hypothesis? Wrong pharmacologic tool? Inadequate experimental design? Comment on the ATPCI trialCarlo Patrono, Leonarda Galiuto
European Heart Journal|October 25, 2020
New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trialLeonarda Galiuto, Carlo Patrono
European Heart Journal|June 23, 2021
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonism and Exercise: An Effective Strategy to Maintain Diet-Induced Weight LossLeonarda Galiuto, Giovanna Liuzzo
European Heart Journal|October 11, 2024
Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fractionMassimo Volpe, Leonarda Galiuto
European Heart Journal|June 7, 2021
Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease riskGiovanna Liuzzo, Leonarda Galiuto
European Heart Journal|September 28, 2023
Higher cardiovascular risk for women throughout the glycaemic spectrum: only a question of sex?Daniela Pedicino, Leonarda Galiuto
European Heart Journal|February 15, 2022
Volume of physical activity and cardiovascular health status: is more necessarily better?Leonarda Galiuto, Giovanna Liuzzo
European Heart Journal|March 7, 2022
Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritisLeonarda Galiuto, Carlo Patrono
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
European Heart Journal|January 6, 2021
Physical activity and mortality reduction: is volume or intensity the key variable?Leonarda Galiuto, Carlo Patrono
European Heart Journal|November 10, 2023
More on aldosterone biosynthesis inhibition and resistant hypertension: a Phase-2 study with lorundrostatMassimo Volpe, Leonarda Galiuto
European Heart Journal|October 14, 2020
Weak hypothesis? Wrong pharmacologic tool? Inadequate experimental design? Comment on the ATPCI trialCarlo Patrono, Leonarda Galiuto
European Heart Journal|October 25, 2020
New hope for targeted treatment of obstructive hypertrophic cardiomyopathy: comment on the EXPLORER-HCM trialLeonarda Galiuto, Carlo Patrono
European Heart Journal|June 23, 2021
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonism and Exercise: An Effective Strategy to Maintain Diet-Induced Weight LossLeonarda Galiuto, Giovanna Liuzzo
European Heart Journal|October 11, 2024
Weekly Journal Scan: FINEARTS-HF supports the role of aldosterone antagonism in the management of heart failure with mildly reduced or preserved ejection fractionMassimo Volpe, Leonarda Galiuto
European Heart Journal|June 7, 2021
Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease riskGiovanna Liuzzo, Leonarda Galiuto
European Heart Journal|September 28, 2023
Higher cardiovascular risk for women throughout the glycaemic spectrum: only a question of sex?Daniela Pedicino, Leonarda Galiuto
European Heart Journal|February 15, 2022
Volume of physical activity and cardiovascular health status: is more necessarily better?Leonarda Galiuto, Giovanna Liuzzo
European Heart Journal|March 7, 2022
Differential cardiovascular effects of disease-modifying antirheumatic drugs in rheumatoid arthritisLeonarda Galiuto, Carlo Patrono
Pageof 13